advancing innovation to save lives

GHTC's statement on the President's FY19 budget

GHTC released a statement in response to the President's fiscal year (FY) 2019 budget proposal, expressing concern about proposed cuts to critical government programs that advance innovation to improve the health of millions of people in need around the world, including Americans.
Learn More

The first step

GHTC released a new two-minute video taking viewers on a journey to discover how sustained investments in global health R&D can unlock health and opportunity for people around the world.

Member Spotlight: Washington Global Health Alliance

The Washington Global Health Alliance (WGHA) strategically connects, expands and strengthens the global health community to advance health equity. WGHA connects people and organizations across disciplines, sectors and ideologies to limit redundancy and increase the impact of its more than 60 organizational members. WGHA's members include global health organizations, businesses, faith-based organizations, and government entities.
Learn More

GHTC works to save and improve lives by encouraging the research and development of essential health technologies. We bring together more than 25 nonprofit organizations, academic institutions, and aligned businesses to advance policies to accelerate the creation of new drugs, vaccines, diagnostics, and other tools that bring healthy lives within reach for all people.

Why we're needed

Health technologies have the potential to save millions of lives. New tools are needed to slow the global threat of diseases, including HIV/AIDS, malaria, tuberculosis, and neglected tropical diseases, and tackle many other pressing health needs. For diseases and conditions primarily affecting people in the world’s poorest places, there is little to no commercial market to spur R&D. Strong investment and innovative solutions are needed to catalyze the development of new technologies to bring health and opportunity within reach for all people.

Learn more
University of Maryland Institute of Human Virology
GHTC welcomes Robert Redfield as CDC director

GHTC sent a letter welcoming Dr. Robert Redfield as the new Centers for Disease Control and Prevention (CDC) director and urging him to prioritize global health R&D at CDC.

GHTC sends FY19 letters to House and Senate appropriators

GHTC sent letters to the relevant House and Senate appropriations subcommittees asking them to sustain and protect global health R&D funding in the fiscal year 2019 (FY19) budget.

Learn More
View All News & Events

GHTC Event

Return on Innovation: How global health R&D is paying dividends in your state
Learn More

GHTC Event

PATH/Gabe Bienczycki
Getting Local with Global Health Security: A Path Toward Sustainable Action
GHTC, GHC, PATH, GHSA Next Generation Network, MSH, GHSAC, NTI
Learn More
View All Events
PATH/Christopher Nelson
Research Roundup: What we’re reading this week

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Read More
The beginning of the end

Phil Carroll, senior policy communications associate at PATH, writes about Marc LaForce, recently retired director of the Meningitis Vaccine Project. This post is part of an ongoing effort on Breakthroughs to highlight leaders and heroes in global health research and development (R&D).

Read More
View Breakthroughs Blog

Our members work to improve health worldwide